Erroneous characterization of nanomaterials can misinform the study of a new medicine’s safety and efficacy.
A South Korean panel that investigated a pulled wolf cloning study ruled today (April 27) that the research team indeed cloned gray wolves, but committed errors in presenting their findings. The journal Cloning and Stem Cells pulled the study linkurl:earlier this month;http://www.the-scientist.com/news/display/53065/ after the authors asked to make changes to the text. Stay tuned for more in-depth coverage on Monday.
April 27, 2007|